The prognostic significance of the serum squamous cell carcinoma antigen (SCCA) levels and other serum markers, including hormones such as prolactin, etc. in cervical carcinoma

CME Journal of Gynecologic Oncology

Volumn 6, Issue 1, 2001, Pages 76-80

  Takeshima, N ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Cervical cancer; Prognosis; Squamous cell carcinoma antigen; Tumor marker

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; HORMONE; PROLACTIN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ANTIGEN DETECTION; ANTIGEN EXPRESSION; CONFERENCE PAPER; FEMALE; HUMAN; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0034899065     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma
2. Value of tumor-antigen (TA-4) of squamous cell carcinoma antigen in predicting the extent of cervical cancer
3. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix
4. Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer
5. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy
6. Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma
7. Cervical carcinoma: A comparison of four potential biochemical tumor markers
8. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma
9. Squamous-cell carcinoma antigen (SCCA-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma
10. Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer
11. The prognostic value of TPA and SCCA in squamous cell carcinoma of the cervix
12. Pretreatment serum squamous cell carcinoma antigen: A newly identified prognostic factor in early-stage cervical carcinoma
13. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervival cancer
14. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical cancer
15. Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinoma
16. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix
17. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix
18. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix
19. Tumor antigens CA 19.9, CA 125, and CEA in carcinoma of the uterine cervix
20. Prognostic significance of serum tumor markers in carcinoma of the cervix
21. Clinical utility of several tumor markers for early detection of recurrence in cervical adenocarcinoma and adenosquamous carcinoma
22. Adenocarcinoma of the uterine cervix
23. The prognostic significance of carcinoembryonic antigen deternimations in patients with adenocarcinoma of the cervix
24. Tumor markers and their prognostic value in adenocarcinoma of the cervix
25. Treatment of carcinoma of the cervix with bromocriptin
26. Ectopic production of prolactin in uterine cervical carcinoma
27. Bromocriptine in the treatment of carcinoma of the cervix: A phase II trial
28. Absence of prolactin receptors in normal and malignant uterine cervix
29. Urinary human gonadotoropin free b-subunit and β-core fragment: A new marker of gynecological cancers
30. Assessment of urinary β-core fragment of hCG as a tumor marker of cervical cancer
31. The prognostic significance of urinary β core fragment in premenopausal women with carcinoma of the cervix